0001490054 false 0001490054 2024-02-12 2024-02-12

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 12, 2024 (February 6, 2024)

 

 

 

VERDE BIO HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Nevada

 

000-54524

 

30-0678378

(State or other Jurisdiction

 

(Commission

 

(IRS Employer

of Incorporation)

 

File Number)

 

Identification No.)

 

PO Box 67

Jacksboro, Texas 76458

(Address of Principal Executive Offices) (Zip Code)

 

(972) 217-4080

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of exchange on which registered

Common Stock, $0.001 par value

 

VBHI

 

OTC Pink

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4I under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).




 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

 

 

Item 1.01.

Entry into a Material Definitive Agreement.

 

 

Spartan Side Letter Agreement

 

As previously reported, on December 11, 2023, Verde Bio Holdings, Inc., a Nevada corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with SensaSure Technologies Inc., a Nevada corporation ( “Parent”), and Formation Minerals Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (“Merger Sub”).

 

Pursuant to the Merger Agreement, Parent agreed to issue to Spartan Capital Securities, LLC, a New York limited liability company (“Spartan”) and/or its designees, on the Closing Date (as defined in the Merger Agreement), a number of shares of common stock, par value $0.01 per share of Parent, (“Parent Common Stock”), such that immediately following the Effective Time (as defined in the Merger Agreement) and the issuance of all shares of Parent Common Stock pursuant to the Merger Agreement, Spartan and/or its designees will own 5,000,000 shares of Parent Common Stock (subject to adjustment in the event of a change in the Company Valuation (as defined in the Merger Agreement), such that in any event Spartan and/or its designees will own a number of shares of Parent Common Stock that is equal to 5.1% of the number of shares of Parent Common Stock issued and outstanding on a fully-diluted basis on the Closing Date and following the Effective Time, such shares the “Spartan Shares”) in consideration for services Spartan provided to the Company. In furtherance of the foregoing, on February 6, 2024, the Company, Parent and Spartan entered into a side letter (the “Side Letter Agreement”) with respect to the Spartan Shares. The Spartan Shares will be offered and sold in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”).

 

Pursuant to the Side Letter Agreement, Parent (i) confirmed its obligation to issue the Spartan Shares pursuant to the Merger Agreement and (ii) agreed that, subject to the terms and conditions of the Side Letter Agreement and the Merger Agreement, and applicable securities laws, if upon an Uplist Event (as defined in the Side Letter Agreement) Spartan’s (and/or its designees’) percentage ownership of Parent Common Stock is less than 4.0% of the number of shares of Parent Common Stock issued and outstanding (and not as a result of Spartan and/or its designees selling, transferring or otherwise disposing of shares of Parent Common Stock), then the Company will promptly issue to Spartan a number of shares of Parent Common Stock such that Spartan will own 4.0% of the number of shares of Parent Common Stock issued and outstanding on a fully-diluted basis immediately following the consummation of such Uplist Event.

 

The forgoing descriptions of the Side Letter Agreement is qualified in its entirety by reference to the full text of such agreement, which is filed hereto as Exhibit 10.1 and incorporated herein by reference.

 

Amendment to Agreement and Plan of Merger

 

On February 8, 2024, the Company, Parent and Merger Sub (collectively, the “Parties”) entered into an amendment (the “Merger Agreement Amendment”) to the Merger Agreement, pursuant to which, among other things, the Parties: (i) clarified Parent’s obligation to issue the Spartan Shares in the form of Parent Common Stock; and (ii) extended the outside termination date of the Merger Agreement from February 1, 2024 to June 30, 2024.


1



Except as stated above, the Merger Agreement Amendment does not result in any other substantive changes to the Merger Agreement, including without limitation changes in the representation and warranties, clauses regarding interim operations of the Company, or any additional covenants.

 

The foregoing description of the Merger Agreement Amendment is a summary only, does not purport to be complete and is qualified in its entirety by the full text of the Merger Agreement Amendment, a copy of which is attached hereto as Exhibit 10.2 and is incorporated herein by reference.

 

Additional Information and Where to Find It

 

In connection with the transactions contemplated in the Merger Agreement, Parent intends to file with the United States Securities and Exchange Commission (“SEC”) a Registration Statement on Form S-4 that will include a joint proxy statement of the Company and Parent (the “Proxy/Registration Statement”) and also will constitute a prospectus with respect to shares of Parent Common Stock to be issued in the proposed transaction. Before making any voting or investment decision, investors and security holders of Parent and the Company and other interested parties are urged to read the Proxy/Registration Statement, any amendments thereto and any other documents filed with the SEC carefully and in their entirety when they become available because they will contain important information about the transaction and the parties to the transaction. Investors and security holders may obtain free copies of the preliminary Proxy/Registration Statement and definitive Proxy/Registration Statement (when available) and other documents filed with the SEC through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by the Parent will be available by contacting the Parent by email at info@pcgadvisory.com. Copies of the documents filed with the SEC by the Company will be available free of charge on the Company’s website at https://investors.verdebh.com/financial-information/sec-filings or by contacting the Company by email at ir@verdebh.com.

 

Participants in the Solicitation

 

The Company, Parent and their respective directors and executive officers and other employees may be considered participants in the solicitation of proxies from the stockholders of the Company with respect to the transaction. Information about the directors and executive officers of the Company is set forth in its Annual Report on Form 10-K for the fiscal year ended April 30, 2023 filed with the SEC on August 2, 2023. Information about the directors and executive officers of Parent is set forth in its Annual Report on Form 10-K for the fiscal year ended April 30, 2023 filed with the SEC on August 14, 2023. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the Proxy/Registration Statement and other relevant materials to be filed with the SEC regarding the transaction when they become available. Stockholders, potential investors and other interested persons should read the Proxy/Registration Statement carefully when it becomes available before making any voting or investment decisions. When available, these documents can be obtained free of charge from the sources indicated above.

 

No Offer or Solicitation

 

This communication shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed business combination. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or an exemption therefrom.

 

Forward-Looking Statements

 

This report contains certain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1955. These forward-looking statements include, without limitation, the Company’s expectations with respect to the proposed merger between the Company, Parent and Merger Sub, including statements regarding the benefits of the transaction and the anticipated timing of the transaction. Words such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions are intended to


2



identify such forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside of the Company’s, Parent's and Merger Sub’s control and are difficult to predict. Factors that may cause actual future events to differ materially from the expected results, include, but are not limited to: (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect the price of the Company’s securities, (ii) the failure to satisfy the conditions to the consummation of the transaction, including the adoption of the Merger Agreement by the stockholders of the Company, (iii) the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement, (iv) the failure to obtain any applicable regulatory approvals required to consummate the business combination, (v) the receipt of an unsolicited offer from another party for an alternative transaction that could interfere with the business combination, (vi) the effect of the announcement or pendency of the transaction on the Company’s business relationships, performance, and business generally, (vii) the inability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition and the ability of the post-combination company to grow and manage growth profitability and retain its key employees, (viii) costs related to the business combination, (ix) the outcome of any legal proceedings that may be instituted against the Company, the Parent or the Merger Sub following the announcement of the proposed business combination, (x) the ability to maintain the listing of the Parent’s securities on the OTC prior to the business combination, (xi) the risk that the Company is not able to maintain and enhance its brand and reputation in its marketplace, adversely affecting the Company’s business, financial condition and results of operations, (xii) the risk that periods of rapid growth and expansion could place a significant strain on the Company’s resources, including its employee base, which could negatively impact the Company’s operating results; (xiii) the risk that Company may never achieve or sustain profitability; (xiv) the risk that Company may need to raise additional capital to execute its business plan, which many not be available on acceptable terms or at all; (xv) the risk that the post-combination company’s securities will not be approved for listing on OTC or if approved, maintain the listing and (xvi) other risks and uncertainties indicated from time to time in the Proxy/Registration Statement. There may be additional risks that the Company does not know or that Company currently believes to be immaterial that could also cause results to differ from those contained in any forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

 

The foregoing list of factors is not exhaustive. Recipients should carefully consider such factors and the other risks and uncertainties described and to be described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K filed for the year ended April 30, 2023 filed with the SEC on August 2, 2023 and subsequent periodic reports filed by Parent with the SEC, the Registration Statement and other documents filed or to be filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Recipients are cautioned not to put undue reliance on forward-looking statements, and neither the Company, nor Parent assumes any obligation to, nor intend to, update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Neither the Company, nor Parent gives any assurance that either the Company or Parent, or the combined company, will achieve its expectations.

 


3



Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

See the Exhibit Index below, which is incorporated by reference herein.

 

Exhibit No.

 

Description

10.1*

 

Side Letter Agreement, dated as of February 6, 2024, by and between Verde Bio Holdings, Inc., SensaSure Technologies Inc. and Spartan Capital Securities, LLC.

10.2*

 

Amendment to the Agreement and Plan of Merger, dated as of February 8, 2024, by and among SensaSure Technologies Inc., Formation Minerals Inc. and Verde Bio Holdings, Inc.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


4



SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Verde Bio Holdings, Inc.

 

 

 

Date: February 12, 2024

By:

/s/ Scott Cox

 

Name:

Scott Cox

 

Title:

Chief Executive Officer

 


February 6, 2024

Spartan Capital Securities, LLC

45 Broadway, 19th Floor

New York, NY 10006

Attention: Kim Monchik, Chief Administrative Officer

Email: kmonchik@spartancapital.com

 

Re:Share Exchange Transaction and Stock Issuance 

Gentlemen:

This side letter agreement (this “Agreement”) is made by and among Verde Bio Holdings, Inc., a Nevada corporation (“Verde”), Sensasure Technologies, Inc., a Nevada corporation (“Parent”), and Spartan Capital Securities, LLC, a New York limited liability company (“Spartan”). This Agreement is made in connection with that certain Agreement and Plan of Merger (the “Merger Agreement”) dated as of December 11, 2023 by and among Verde, Parent, and Formation Minerals Inc., a Nevada corporation, and a wholly-owned subsidiary of Parent. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Merger Agreement.

In connection with and pursuant to Section 7.1(e)(ii) of the Merger Agreement, and in consideration for Spartan’s efforts in connection therewith, the parties hereto hereby agree as follows:

1.Issuance of Parent Common Stock. On the Closing Date, Parent shall issue to Spartan a number of shares of Parent Common Stock so that Spartan and/or its designees shall own 5,000,000 of shares of Parent Common Stock (subject to adjustment in the event of change in Verde’s fair market valuation under the Merger Agreement), and in any event the number of shares of Parent Common Stock that is equal to five and one-tenth (5.1%) of the number of shares of Parent Common Stock issued and outstanding on the Closing Date, on a pro forma basis. For the avoidance of doubt and for the purposes hereof, the total number of issued and outstanding shares of Parent Common Stock shall include any shares of Parent Common Stock that are issued and/or to be issued pursuant to the Merger Agreement (including, without limitation, pursuant to Section 2.12 of the Merger Agreement, Section 7.1(e)(i), and the shares of Parent Common Stock issuable to Spartan pursuant to Section 7.1(e)(ii)), this Agreement, and any other agreements, contracts, and/or documents related to Parent or Verde. 

2.Antidilution. Subject to the terms and conditions of this Agreement and the Merger Agreement, and applicable securities laws, if upon an Uplist Event Spartan’s percentage ownership of Parent Common Stock is less than four percent (4.0%) of the number of shares of Parent Common Stock issued and outstanding (and not as a result of Spartan selling, transferring or otherwise disposing of shares of Parent Common Stock), then Parent shall promptly issue to Spartan and/or its designees a number of shares of Parent Common Stock so that Spartan and/or its designees shall own four percent (4.0%) of the number of shares of Parent Common Stock issued and outstanding subsequent to such Uplist Event. For the avoidance of doubt, if such Uplist Event includes a capital raise whereby any shares of Parent Common Stock are issued, then such shares shall be deemed issued and outstanding as of the date of the Uplist Event. As used herein, “Uplist Event” shall mean the listing of the Parent Common Stock on any of the Nasdaq Global Market, Nasdaq Capital Market, New York Stock Exchange, NYSE American, or CBOE. 

3.Compliance with Laws. Notwithstanding any provision of this Agreement to the contrary, the issuance of Parent Common Stock will be subject to compliance with all applicable requirements of  


-1-


federal, state, or foreign law with respect to such securities and with the requirements of any regulatory body or stock exchange or market system upon which the Parent Common Stock may then be listed. Parent Common Stock will be issued hereunder if such issuance would constitute a violation of any applicable federal, state, or foreign securities laws or other law or regulations or the requirements of any regulatory body or stock exchange or market system upon which the Parent Common Stock may then be listed. The inability of the Parent to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Parent’s legal counsel to be necessary to the lawful issuance and sale of any shares subject to this Agreement will relieve the Parent of any liability in respect of the failure to issue such shares as to which such requisite authority has not been obtained. Parent shall use its reasonable efforts to obtain any such authority.

4.Jurisdiction and Governing Law. This Agreement will be governed by and construed in accordance with the laws of the State of New York, without regard to principles of conflicts of law. Any controversy between the parties to this Agreement, or arising out of the Agreement, shall be resolved by arbitration before the American Arbitration Association (“AAA”) or FINRA Arbitration (“FINRA”) in New York, New York. The following arbitration agreement should be read in conjunction with these disclosures: 

a)ARBITRATION IS FINAL AND BINDING ON THE PARTIES. 

 

b)THE PARTIES ARE WAIVING THEIR RIGHT TO SEEK REMEDIES IN COURT, INCLUDING THE RIGHT TO JURY TRIAL. 

 

c)PRE-ARBITRATION DISCOVERY IS GENERALLY MORE LIMITED THAN AND DIFFERENT FROM COURT PROCEEDING; AND 

 

d)THE ARBITRATORS’ AWARD IS NOT REQUIRED TO INCLUDE FACTUAL FINDING OR LEGAL REASONING AND ANY PARTY’S RIGHT TO APPEAL OR TO SEEK MODIFICATION OF RULINGS BY THE ARBITRATORS IS STRICTLY LIMITED. 

5.ARBITRATION AGREEMENT. ANY AND ALL CONTROVERSIES, DISPUTES OR CLAIMS BETWEEN SPARTAN AND YOU OR YOUR AGENTS, REPRESENTATIVES, EMPLOYEES, DIRECTORS, OFFICERS OR CONTROL PERSONS, ARISING OUT OF, IN CONNECTION WITH, OR WITH RESPECT TO (i) ANY PROVISIONS OF OR THE VALIDITY OF THIS AGREEMENT OR ANY RELATED AGREEMENTS, (ii) THE RELATIONSHIP OF THE PARTIES HERETO, OR (iii) ANY CONTROVERSY ARISING OUT OF YOUR BUSINESS SHALL BE CONDUCTED BY THE AMERICAN ARBITRATION ASSOCIATION UNDER ITS COMMERCIAL ARBITRATION RULES. ARBITRATION MUST BE COMMENCED BY SERVICE OF A WRITTEN DEMAND FOR ARBITRATION OR A WRITTEN NOTICE OF INTENTION TO ARBITRATE. IF YOU ARE A PARTY TO SUCH ARBITRATION, TO THE EXTENT PERMITTED BY THE RULES OF THE APPLICABLE ARBITRATION TRIBUNAL, THE ARBITRATION SHALL BE CONDUCTED IN NEW YORK, NEW YORK. THE DECISION AND AWARD OF THE ARBITRATORS(S) SHALL BE CONCLUSIVE AND BINDING UPON ALL PARTIES, AND ANY JUDGMENT UPON ANY AWARD RENDERED MAY BE ENTERED IN THE STATE OR FEDERAL COURTS LOCATED IN NEW YORK, NEW YORK, OR ANY OTHER COURT HAVING JURISDICTION THEREOF, AND NEITHER PARTY SHALL OPPOSE SUCH ENTRY. 

6.   Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other documents, agreements,  


-2-


certificates and instruments, as the other parties may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions consummated hereby.

7.Enforceability. If any term in this Agreement is deemed invalid or unenforceable, such term shall be deemed to be modified or limited to the extent necessary to make the term valid and enforceable, or if such modification or limitation will not have the desired effect, the term shall no longer form part of this Agreement and shall not have any effect upon the validity or enforceability of the remaining terms set out in this Agreement. 

8.Entire Agreement. This Agreement and the documents and instruments and other agreements among the Parties as contemplated by or referred to herein, constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, both written and oral, among the parties with respect to the subject matter hereof. 

9.Headings; Severability. The headings used in this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement. In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the parties. 

10. No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. 

 

11.     Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument. Any such counterpart, to the extent delivered by .pdf, .tif, .gif, .jpg or similar attachment to electronic mail, will be treated in all manner and respects as an original executed counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. 

 

[Signature page(s) to follow.]


-3-


IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

VERDE BIO HOLDINGS, INC.

By: /s/ Scott Cox

Title: Chief Executive Officer

 

 

SENSASURE  TECHNOLOGIES INC.

 

By: /s/ James Hiza

Title: Chief Executive Officer

 

Acknowledged:

SPARTAN CAPITAL SECURITIES, LLC

By: /s/ Kim Monchik

Name: Kim Monchik

Title: Chief Administrative Officer


-4-

 

AMENDMENT TO

AGREEMENT AND PLAN OF MERGER

This Amendment to Agreement and Plan of Merger (this “Amendment”) is made and entered into as of February 8, 2024, by and among SensaSure Technologies Inc., a Nevada corporation (“Parent”), Formation Minerals Inc., a Nevada corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and Verde Bio Holdings, Inc., a Nevada corporation (the “Company”).

WHEREAS, the Agreement and Plan of Merger was made and entered into as of December 11, 2023, by and among Parent, Merger Sub and the Company (the “Merger Agreement”; capitalized terms used, but not defined, herein shall have the same definition ascribed thereto in the Merger Agreement);

WHEREAS, Section 8.4 of the Merger Agreement provides that the Merger Agreement may be amended by Parent, Merger Sub and the Company at any time by the execution of an instrument in writing signed on behalf of each of Parent, Merger Sub and the Company; and

WHEREAS, Parent, Merger Sub and the Company desire to amend Section 8.1(c) of the Merger Agreement as set forth herein.

NOW, THEREFORE, in consideration of the mutual promises contained in this Amendment and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows:

1.Amendment to the Merger Agreement.  

a.Section 6.2(a) of the Merger Agreement is hereby amended and restated in its entirety to read as follows: 

“(a) Preparation. Promptly after the execution of this Agreement the Company will prepare (with Parent’s reasonable cooperation) and file as promptly as practicable with the SEC a preliminary proxy statement to be sent to the Company Stockholders in connection with the Company Stockholder Meeting (the proxy statement, including any amendments or supplements, the “Proxy Statement”) for the purpose of soliciting proxies from Company Stockholders for the matters to be acted upon at the Company Stockholder Meeting and providing the Company Stockholders an opportunity in accordance with the Company’s Charter and Bylaws to have their shares of Company Capital Stock redeemed (the “Redemption”) in conjunction with the stockholder vote, which shall include a joint registration statement (the “Registration Statement”) relating to the registration under the Securities Act of the Merger Consideration Shares. The Company will not file the Proxy Statement with the SEC without first providing Parent and its counsel a reasonable opportunity to review


and comment thereon, and the Company will give due consideration to all reasonable additions, deletions or changes suggested by Parent or its counsel. Subject to Section 5.3, the Company must include the Company Board Recommendation in the Proxy Statement. The Company will use its reasonable best efforts to resolve all SEC comments, if any, with respect to the Proxy Statement as promptly as practicable after receipt thereof. Promptly following confirmation by the SEC that the SEC has no further comments, the Company will cause the Proxy Statement in definitive form to be mailed to the Company Stockholders.”

b.Section 7.1(e)(ii) of the Merger Agreement is hereby amended and restated in its entirety to read as follows: 

“(ii) Following the Closing, the Parent shall issue to the Company Advisor a number of shares of Parent Common Stock, such that immediately following the Effective Time and the issuance of all shares of Parent Common Stock pursuant to this Agreement, Spartan will own 5,000,000 shares of Parent Common Stock (subject to adjustment in the event of a change in the Company Valuation, such that in any event Spartan will own a number of shares of Parent Common Stock that is equal to 5.1% of the Parent Common Stock issued and outstanding (on a fully-diluted basis) on the Closing Date and following the Effective Time), as may be adjusted or otherwise modified by agreement of Company Advisor and Parent.”

c.Section 8.1(c) of the Merger Agreement is hereby amended and restated in its entirety to read as follows: 

“(c) by either Parent or the Company if the Effective Time has not occurred by 11:59 p.m., Eastern Standard time, on June 30, 2024 (such time and date as it may be extended by mutual written agreement of Parent and the Company, the “Termination Date”), it being understood that the right to terminate this Agreement pursuant to this Section 8.1(c) will not be available if the terminating Party’s material breach of any provision of this Agreement is the primary cause of the failure of the Merger to be consummated by the Termination Date;”

d.Schedule 2.7 of the Merger Agreement is hereby amended and restated in its entirety as set forth on Schedule 2.7 attached hereto. 

2.No Other Modification. Except as specifically amended by the terms of this Amendment, all terms and conditions set forth in the Merger Agreement shall remain in full force and effect, as applicable. 

 

-2-


 

 

3.Governing Law. This Amendment shall be governed by, and construed in accordance with, the laws of the State of Nevada, without regard to any rule or principle that might refer the governance or construction of this Amendment to the Laws of another jurisdiction. 

 

4.Entire Agreement. This Amendment contains the entire agreement and understanding of the parties hereto with respect to the subject matter contained therein and may not be contradicted by evidence of any alleged oral agreement. 

 

5.Further Assurances. Each party to this Amendment agrees to perform any further acts and execute and deliver any documents that may be reasonably necessary to carry out the provisions of this Amendment. 

 

6.Counterparts. This Amendment may be executed in multiple counterparts, each of which shall be deemed an original and all of which, together, shall constitute one and the same instrument. Facsimile, .pdf and other electronic execution and delivery of this consent is legal, valid and binding for all purposes. 

 

7.Headings. The descriptive headings of the various provisions of this Amendment are inserted for convenience of reference only and shall not be deemed to affect the meaning or construction of any of the provisions hereof. 

 

[Remainder of Page Intentionally Left Blank]

 

 

 

 

 

 

 

 

 

 

 

-3-


 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Amendment to be effective for all purposes as of the date first above written.

 

SENSASURE TECHNOLOGIES INC.

By:

/s/ James Hiza

Name:

James Hiza

Title:

CEO

 

 

 

 

FORMATION MINERALS INC.

By:

/s/ James Hiza

Name:

James Hiza

Title:

CEO

 

 

 

 

VERDE BIO HOLDINGS, INC.

By:  

/s/ Scott Cox

Name:

 

Title:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[Signature Page to Amendment to Agreement and Plan of Merger]


 

 

Schedule 2.7

 

As of the date of the Agreement:

 

Company Valuation: $10,000,000

 

Merger Consideration: 1,755,077,167 shares of Company Common Stock; 500,000 shares of Company Series A Preferred Stock; 788 shares of Company Series C Preferred Stock (convertible into 1,891,200,000 shares of Company Common Stock).

 

 

Parent Stock Price:

 

Parent Common Stock shall have a per share price of $0.75.

Parent Series A Preferred Stock shall have a per share price of $0.75.

Parent Series B Preferred Stock shall have a per share price of $0.75.

 

 

Merger Consideration Shares:

 

Each holder of Company Common Stock shall receive, in consideration for every 273.5 shares of Company Common Stock, 1 share of Parent Common Stock.

 

Each holder of Company Series A Preferred Stock shall receive, in consideration for every 273.5 shares of Company Series A Preferred Stock, 1 share of Parent Class A Preferred Stock.

 

Each holder of Company Series C Preferred Stock shall receive, in consideration for every 0.14 shares of Company Series C Preferred Stock, 1 share of Parent Class B Preferred Stock.

 

 

At the Effective Time (to be completed by the parties in advance of the Effective Time):

 

Company Valuation: $[ ]

 

Merger Consideration: $[ ]

 

Parent Stock Price:

 

Parent Common Stock shall have a per share price of $[ ].

Parent Series A Preferred Stock shall have a per share price of $[ ].

Parent Series B Preferred Stock shall have a per share price of $[ ].

 

Merger Consideration Shares:

 

Each holder of Company Common Stock shall receive, in consideration for every [ ] shares of Company Common Stock, 1 share of Parent Common Stock.

 

Each holder of Company Series A Preferred Stock shall receive, in consideration for every [ ] shares of Company Series A Preferred Stock, 1 share of Parent Class A Preferred Stock.

 

Each holder of Company Series C Preferred Stock shall receive, in consideration for every [ ] shares of Company Series C Preferred Stock.